Your browser version may not work well with NCBI's Web applications. More information here...
1: Biochim Biophys Acta. 2000 Dec 15;1529(1-3):9-18.
Related Articles, Links
Click here to read
The structure of the catalytic portion of human HMG-CoA reductase.

Istvan ES, Deisenhofer J.

Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9050, USA.

In higher plants, fungi, and animals isoprenoids are derived from the mevalonate pathway. The carboxylic acid mevalonate is formed from acetyl-CoA and acetoacetyl-CoA via the intermediate 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA). The four-electron reduction of HMG-CoA to mevalonate, which utilizes two molecules of NADPH, is the committed step in the biosynthesis of isoprenoids. This reaction is catalyzed by HMG-CoA reductase (HMGR). The activity of HMGR is controlled through synthesis, degradation and phosphorylation. The human enzyme has also been targeted successfully by drugs, known as statins, in the clinical treatment of high serum cholesterol levels. The crystal structure of the catalytic portion of HMGR has been determined recently with bound reaction substrates and products. The structure illustrates how HMG-CoA and NADPH are recognized and suggests a catalytic mechanism. Catalytic portions of human HMGR form tight tetramers, explaining the influence of the enzyme's oligomeric state on the activity and suggesting a mechanism for cholesterol sensing.

Publication Types:
PMID: 11111074 [PubMed - indexed for MEDLINE]